Bristol-Myers Squibb Co (BMY)
58.51
+0.10
(+0.17%)
USD |
NYSE |
Nov 14, 16:00
58.17
-0.34
(-0.58%)
After-Hours: 20:00
Bristol-Myers Squibb Cash and Short Term Investments (Quarterly): 8.094B for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 8.094B |
| June 30, 2024 | 6.653B |
| March 31, 2024 | 9.67B |
| December 31, 2023 | 12.28B |
| September 30, 2023 | 7.685B |
| June 30, 2023 | 8.73B |
| March 31, 2023 | 9.269B |
| December 31, 2022 | 9.253B |
| September 30, 2022 | 9.027B |
| June 30, 2022 | 13.27B |
| March 31, 2022 | 15.20B |
| December 31, 2021 | 17.22B |
| September 30, 2021 | 15.82B |
| June 30, 2021 | 14.02B |
| March 31, 2021 | 13.14B |
| December 31, 2020 | 16.45B |
| September 30, 2020 | 21.28B |
| June 30, 2020 | 21.79B |
| March 31, 2020 | 18.32B |
| December 31, 2019 | 15.39B |
| September 30, 2019 | 32.54B |
| June 30, 2019 | 29.36B |
| March 31, 2019 | 8.764B |
| December 31, 2018 | 8.759B |
| September 30, 2018 | 6.83B |
| Date | Value |
|---|---|
| June 30, 2018 | 6.075B |
| March 31, 2018 | 6.77B |
| December 31, 2017 | 6.812B |
| September 30, 2017 | 7.122B |
| June 30, 2017 | 6.505B |
| March 31, 2017 | 6.109B |
| December 31, 2016 | 6.35B |
| September 30, 2016 | 5.56B |
| June 30, 2016 | 4.651B |
| March 31, 2016 | 4.307B |
| December 31, 2015 | 4.27B |
| September 30, 2015 | 5.413B |
| June 30, 2015 | 5.476B |
| March 31, 2015 | 7.607B |
| December 31, 2014 | 7.435B |
| September 30, 2014 | 7.221B |
| June 30, 2014 | 7.175B |
| March 31, 2014 | 7.059B |
| December 31, 2013 | 4.525B |
| September 30, 2013 | 2.722B |
| June 30, 2013 | 2.799B |
| March 31, 2013 | 2.533B |
| December 31, 2012 | 2.829B |
| September 30, 2012 | 2.93B |
| June 30, 2012 | 5.037B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
6.653B
Minimum
Jun 2024
21.79B
Maximum
Jun 2020
13.13B
Average
13.20B
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Amgen Inc | 9.011B |
| Johnson & Johnson | 20.30B |
| Eli Lilly and Co | 3.518B |
| Merck & Co Inc | 14.59B |
| Pfizer Inc | 9.952B |